Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 10,336.00p on 04-07-2025 at 18:35:10
Change 132.00p 1.29%
Buy 10,378.00p
Sell 10,374.00p
Buy / Sell AZN Shares
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Unknown 78.00 at 10,236.68793p
Day's Volume: 927,092
Last Close: 10,336.00p
Open: 10,130.00p
ISIN: GB0009895292
Day's Range 10,122.00p - 10,416.00p
52wk Range: 9,574.00p - 13,338.00p
Market Capitalisation: £160,232m
VWAP: 10,241.08891p
Shares in Issue: 1,550m

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Lower Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 78 10,236.68793p Currency Conversion
Negotiated Trade
OTC Trade
 17:34:05 - 04-Jul-25
Unknown* 238 10,299.64854p Currency Conversion
Negotiated Trade
OTC Trade
 17:34:05 - 04-Jul-25
Sell* 727 10,206.851p SI Trade
 16:40:53 - 04-Jul-25
Sell* 727 10,204.81p SI Trade
 16:40:53 - 04-Jul-25
Sell* 493 10,206.85p SI Trade
 16:40:53 - 04-Jul-25
Sell* 493 10,204.81p SI Trade
 16:40:53 - 04-Jul-25
Sell* 381 10,206.853p SI Trade
 16:40:53 - 04-Jul-25
Sell* 381 10,204.81p SI Trade
 16:40:53 - 04-Jul-25
Unknown* 20,439 10,336.00p OTC Trade
 16:35:15 - 04-Jul-25
Unknown* 7,988 10,336.00p OTC Trade
 16:35:15 - 04-Jul-25
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
4th Jul 2025 (Fri) 10,130.00 10,416.00 10,122.00 10,336.00 927,092
3rd Jul 2025 (Thu) 10,394.00 10,466.00 10,112.00 10,204.00 1,996,475
2nd Jul 2025 (Wed) 10,446.00 10,466.00 10,326.00 10,390.00 2,527,463
1st Jul 2025 (Tue) 10,140.00 10,440.00 10,104.00 10,402.00 1,739,587
30th Jun 2025 (Mon) 10,216.00 10,236.00 10,120.00 10,120.00 2,343,106
27th Jun 2025 (Fri) 10,168.00 10,260.00 10,148.00 10,224.00 1,298,387
26th Jun 2025 (Thu) 10,184.00 10,250.00 10,144.00 10,144.00 4,207,995
25th Jun 2025 (Wed) 10,320.00 10,368.00 10,230.00 10,248.00 2,081,733
24th Jun 2025 (Tue) 10,546.00 10,606.00 10,266.00 10,332.00 4,086,975
23rd Jun 2025 (Mon) 10,324.00 10,464.00 10,310.00 10,420.00 1,753,966
20th Jun 2025 (Fri) 10,610.00 10,628.00 10,378.00 10,392.00 4,603,600
19th Jun 2025 (Thu) 10,454.00 10,620.00 10,454.00 10,552.00 815,123
18th Jun 2025 (Wed) 10,500.00 10,566.00 10,460.00 10,548.00 1,422,939
17th Jun 2025 (Tue) 10,702.00 10,838.00 10,598.00 10,662.00 2,576,908
16th Jun 2025 (Mon) 10,906.00 10,978.00 10,818.00 10,818.00 2,181,456
13th Jun 2025 (Fri) 10,924.00 11,076.00 10,904.00 10,986.00 1,985,713
12th Jun 2025 (Thu) 10,900.00 11,086.00 10,882.00 11,030.00 1,172,128
11th Jun 2025 (Wed) 10,866.00 10,908.00 10,746.00 10,906.00 1,718,028
10th Jun 2025 (Tue) 10,812.00 10,894.00 10,728.00 10,872.00 909,868
9th Jun 2025 (Mon) 10,788.00 10,826.00 10,700.00 10,772.00 629,321
6th Jun 2025 (Fri) 10,774.00 10,790.00 10,676.00 10,782.00 1,034,794
5th Jun 2025 (Thu) 10,808.00 10,826.00 10,614.00 10,700.00 1,238,322
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
4th Jul 2025 7:00 am RNS Imfinzi approved in the EU for bladder cancer
1st Jul 2025 3:00 pm RNS Total Voting Rights
24th Jun 2025 7:00 am RNS Datroway approved in US for EGFRm lung cancer
17th Jun 2025 11:45 am RNS Holding(s) in Company
13th Jun 2025 9:30 am RNS AstraZeneca enters into collaboration with CSPC
12th Jun 2025 3:00 pm RNS Director/PDMR Shareholding
6th Jun 2025 7:00 am RNS Fixed-duration Calquence approved in EU for 1L CLL
2nd Jun 2025 3:05 pm RNS Block listing Interim Review
2nd Jun 2025 3:00 pm RNS Total Voting Rights
27th May 2025 7:00 am RNS Imfinzi recommended in EU for bladder cancer
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

CORRECT: AstraZeneca bladder cancer treatment secures EU approval

4th Jul 2025 17:19

(Correcting name of trial, primary endpoint and Dave Fredrickson's title.) Read More

LONDON MARKET CLOSE: Stocks fade as tariff deadline looms large

4th Jul 2025 16:58

(Alliance News) - London's FTSE 100 ended flat as tariff worries kept enthusiasm to a minimum on Friday, while the pound edged slightly lower after a dramatic week in Westminster. Read More

LONDON MARKET MIDDAY: Europe down ahead of US tariff decision deadline

4th Jul 2025 11:58

(Alliance News) - London's blue chip index remained lower at midday on Friday, as investors weigh China's decision to slap levies on major European brandy exporters, and as US trading partners brace for letters on their respective tariff rates. Read More

AstraZeneca bladder cancer treatment Imfinzi secures EU approval

4th Jul 2025 08:02

(Alliance News) - AstraZeneca PLC on Friday said Imfinzi is "poised to transform the standard of care" as it reported the bladder cancer treatment cleared a European regulatory milestone. Read More

LONDON BRIEFING: AstraZeneca wins EU nod for bladder cancer therapy

4th Jul 2025 07:58

(Alliance News) - London's FTSE 100 is called lower on Friday, as investors await a potential US announcement on tariff rates for trading partners and the UK prime minister reflects on his "good relationship" with US President Donald Trump. Read More

See more Astrazeneca news
FTSE 100 Latest
Value8,822.91
Change-0.29

Login to your account

Forgot Password?

Not Registered